Literature DB >> 15387356

Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

F Magro1, F Araujo, P Pereira, E Meireles, M Diniz-Ribeiro, F Tavarela Velosom.   

Abstract

The endothelium is involved in the pathogenesis of inflammatory bowel disease (IBD). So far knowledge of the precise role of soluble adhesion molecules and angiogenic factors at different periods of activity in IBD is scarce or contradictory. Our goal in this study was to determine the serum levels of adhesion molecules and angiogenic factors in IBD patients at different periods of disease activity--clinical remission, biochemical evidence of inflammation, and clinical evidence of activity. We used a cross-sectional study design consisting of 218 patients (145 with Crohn's disease [CD] and 73 with ulcerative colitis [UC]) and 115 randomly assymptomatic blood donors. To assess disease activity, Harvey and Bradshaw's and Truelove-Witts' indexes were used. Circulating plasma sE-selectin (sE-S), sP-selectin (sP-S), human soluble vascular cell adhesion molecule-1 (sVCAM-1), and human soluble intercellular adhesion molecule-1 (sICAM-1) and serum levels of human vascular endothelial growth factor (VEGF), angiogenin (ANG), and placenta growth factor (P/GF) were measured with ELISAs. The amount of mRNA VEGF in blood mononuclear cells was also evaluated. In inactive CD patients, serum levels of sP-S, sE-S, sVCAM, and sICAM were significantly lower (P < 0.05) than in controls. In active CD patients, only the sE-S values were higher than in controls. In UC patients, sP-S and sVCAM levels were significantly lower than those in controls. Considering growth factors, CD patients in remission had levels of ANG and VEGF lower than those found in controls. The VEGF RNAm in blood mononuclear cells was similar among all CD activity groups. In conclusion, in UC patients the serum levels of VEGF, ANG, and P/GF were similar to those in controls. The serum levels of adhesion molecules and angiogenic factors were low in IBD patients in periods of remission. Low levels of angiogenic factors in inactive CD patients suggest dysfunction of the angiogenic process and wound repair.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15387356     DOI: 10.1023/b:ddas.0000037822.55717.31

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

Review 1.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

2.  Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease.

Authors:  J B Seidelin; B Vainer; T Horn; O H Nielsen
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

3.  Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.

Authors:  M Göke; J C Hoffmann; J Evers; H Krüger; M P Manns
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 4.  Gastrointestinal mucosal regeneration: role of growth factors.

Authors:  M K Jones; M Tomikawa; B Mohajer; A S Tarnawski
Journal:  Front Biosci       Date:  1999-03-15

5.  Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.

Authors:  T Griga; E Voigt; B Gretzer; F Brasch; B May
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

6.  Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.

Authors:  S Jimi; K Ito; K Kohno; M Ono; M Kuwano; Y Itagaki; H Ishikawa
Journal:  Biochem Biophys Res Commun       Date:  1995-06-15       Impact factor: 3.575

7.  Angiogenins: a new class of microbicidal proteins involved in innate immunity.

Authors:  Lora V Hooper; Thaddeus S Stappenbeck; Chieu V Hong; Jeffrey I Gordon
Journal:  Nat Immunol       Date:  2003-01-27       Impact factor: 25.606

8.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

Authors:  D R Senger; S R Ledbetter; K P Claffey; A Papadopoulos-Sergiou; C A Peruzzi; M Detmar
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

9.  Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease.

Authors:  G M Schuermann; A E Aber-Bishop; P Facer; J C Lee; D S Rampton; C J Doré; J M Polak
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

10.  Requirement for sialic acid on the endothelial ligand of a lymphocyte homing receptor.

Authors:  D D True; M S Singer; L A Lasky; S D Rosen
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  17 in total

Review 1.  Current advantages in the application of proteomics in inflammatory bowel disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; George Theodoropoulos; George Zografos
Journal:  Dig Dis Sci       Date:  2012-06-28       Impact factor: 3.199

2.  Adhesion molecules in chronic ulcerative colitis.

Authors:  Maya V Gulubova; Irena M Manolova; Tatyana I Vlaykova; Margarita Prodanova; Jovcho P Jovchev
Journal:  Int J Colorectal Dis       Date:  2006-11-16       Impact factor: 2.571

3.  CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis.

Authors:  Yuzhen Zhu; Yanling Feng; Hongbo Liu; Hua Ye; Cancan Guo; Jinshan Feng; Shixue Dai; Xuebao Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine.

Authors:  Huaijun Wang; Stephen A Felt; Ismayil Guracar; Valentina Taviani; Jianhua Zhou; Rosa Maria Silveira Sigrist; Huiping Zhang; Joy Liau; José G Vilches-Moure; Lu Tian; Yamil Saenz; Thierry Bettinger; Brian A Hargreaves; Amelie M Lutz; Jürgen K Willmann
Journal:  Eur Radiol       Date:  2017-11-23       Impact factor: 5.315

Review 5.  Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Authors:  Evangelos Voudoukis; Konstantinos Karmiris; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 6.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 7.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

8.  Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model.

Authors:  Huaijun Wang; Steven Machtaler; Thierry Bettinger; Amelie M Lutz; Richard Luong; Philippe Bussat; Sanjiv S Gambhir; François Tranquart; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2013-01-31       Impact factor: 11.105

9.  Myeloid cells protect intestinal epithelial barrier integrity through the angiogenin/plexin-B2 axis.

Authors:  Rongpan Bai; Desen Sun; Muxiong Chen; Xiaoliang Shi; Liang Luo; Zhengrong Yao; Yaxin Liu; Xiaolong Ge; Xiangwei Gao; Guo-Fu Hu; Wei Zhou; Jinghao Sheng; Zhengping Xu
Journal:  EMBO J       Date:  2020-06-08       Impact factor: 11.598

Review 10.  New serological biomarkers of inflammatory bowel disease.

Authors:  Xuhang Li; Laurie Conklin; Philip Alex
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.